Overview
- Amy Carding began a prescribed weekly tirzepatide (Mounjaro) regimen in October 2024 and over 18 months lost 5st 8lb, moving from size 22 to size 12.
- Her weight fell from a peak BMI of 44.8 to a BMI of 30.2, which the NHS classifies as obese, and she plans to remain on the medication following GP and pharmacist advice.
- Carding credits the drug for reducing her appetite and credits diet changes plus about 15,000 steps a day for sustaining steady weekly losses.
- She experienced nausea a few months into treatment and said Sea-Band acupressure bands helped relieve symptoms.
- Carding uses TikTok to document weekly weigh-ins and what she eats, earning enough revenue to help cover roughly £300 a month for injections and underscoring how some people are privately funding GLP-1–class treatments.